Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 89 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $856,642 | -19.7% | 157,182 | 0.0% | 0.08% | -33.6% |
| Q2 2023 | $1,067,266 | +144.3% | 157,182 | +80.3% | 0.12% | +164.4% |
| Q1 2023 | $436,782 | +2.7% | 87,182 | 0.0% | 0.04% | -26.2% |
| Q4 2022 | $425,448 | -66.2% | 87,182 | 0.0% | 0.06% | -64.3% |
| Q3 2022 | $1,257,000 | -39.0% | 87,182 | -36.0% | 0.17% | -46.7% |
| Q2 2022 | $2,060,000 | -27.4% | 136,182 | -43.0% | 0.32% | -12.3% |
| Q1 2022 | $2,839,000 | -43.6% | 238,982 | -23.0% | 0.37% | -27.4% |
| Q4 2021 | $5,033,000 | -33.6% | 310,494 | +16.9% | 0.50% | -57.4% |
| Q3 2021 | $7,583,000 | +55.5% | 265,700 | +84.1% | 1.18% | +57.6% |
| Q2 2021 | $4,877,000 | – | 144,300 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $1,041,909 | 4.24% |
| Sofinnova Investments, Inc. | 2,194,278 | $11,958,815 | 0.75% |
| DENALI ADVISORS LLC | 85,900 | $468,155 | 0.16% |
| Polar Capital Holdings Plc | 2,103,298 | $11,462,974 | 0.08% |
| Soleus Capital Management, L.P. | 157,182 | $856,642 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 137,299 | $748 | 0.06% |
| Caligan Partners LP | 23,321 | $127,099 | 0.06% |
| Corton Capital Inc. | 12,244 | $66,730 | 0.03% |
| RICE HALL JAMES & ASSOCIATES, LLC | 91,249 | $497,307 | 0.03% |
| CIM INVESTMENT MANAGEMENT INC | 15,313 | $83,456 | 0.03% |